MOLECULAR APPROACHES TO CANCER IMMUNOTHERAPY
MOLECULAR APPROACHES TO CANCER IMMUNOTHERAPY
批准号:
3434322
负责人:
RALPH A. REISFELD
金额:
$0.3万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-09-30 至 1994-09-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Support is requested for a scientific meeting organized by the American
Association for Cancer Research. The conference, entitled "Molecular
Approaches to Cancer Immunotherapy," will be held at the Grove Park inn
in Asheville, NC, on November 7-11, 1993. The conference chairperson is
the Principal investigator, Dr. Ralph A. Reisfeld.
The major goals of the conference are to provide an in-depth evaluation
of what is known about cancer immunotherapy, the molecular nature of the
immune response to cell surface antigens or to exogenous antigens, and the
significance of the rapid advances in DNA technologies and biotechnology,
as well as the appropriate consideration of advances in the understanding
of what triggers immune cell activity.
Twenty-nine distinguished scientists will deliver talks, and registrants
will have the opportunity to give poster presentations of their own work.
The conference will bring together a group of world class experts in
different areas of cancer immunotherapy whose work is indicative of the
new and exciting approaches to cancer treatment. These research
developments have been made possible by the substantial progress made
during the last decade in three major research areas: First, there have
been great strides towards a better understanding of the molecular nature
of the immune response to cell surface antigens or to exogenous antigens
presented in conjunction with major histocompatibility complex molecules.
Second, the rapid advances in recombinant DNA technologies and in
biotechnology as a whole have made it possible to obtain large amounts of
molecularly defined biological molecules such as monoclonal antibodies,
cytokines, and growth factors. Third, there have been advances in our
understanding of what triggers immune cell activity. These insights have
led to novel gene therapy approaches that may overcome the frustrating
inability of the immune defense system to cope with human cancer.
This will be the twenty-seventh meeting in an outstanding series of
special conferences organized by the Association. The organizers believe
that it will present a unique opportunity for investigators working in
rapidly developing scientific areas to exchange new ideas and develop
novel conceptual approaches to their research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting of STAT3 Signaling Enhances Efficacy of Breast Cancer Immunotherapy
-
批准号:8034729
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2009
-
负责人:RALPH A. REISFELD
-
依托单位:
Targeting of STAT3 Signaling Enhances Efficacy of Breast Cancer Immunotherapy
-
批准号:7663038
-
项目类别:
-
资助金额:$39.4万
-
财政年份:2009
-
负责人:RALPH A. REISFELD
-
依托单位:
Fra-1: A new target for a genomic breast cancer vaccine
-
批准号:7360310
-
项目类别:
-
资助金额:$32.66万
-
财政年份:2006
-
负责人:RALPH A. REISFELD
-
依托单位:
Fra-1: A new target for a genomic breast cancer vaccine
-
批准号:7100348
-
项目类别:
-
资助金额:$33.0万
-
财政年份:2006
-
负责人:RALPH A. REISFELD
-
依托单位:
Fra-1: A new target for a genomic breast cancer vaccine
-
批准号:7574393
-
项目类别:
-
资助金额:$32.66万
-
财政年份:2006
-
负责人:RALPH A. REISFELD
-
依托单位:
Fra-1: A new target for a genomic breast cancer vaccine
-
批准号:7212238
-
项目类别:
-
资助金额:$32.04万
-
财政年份:2006
-
负责人:RALPH A. REISFELD
-
依托单位:
NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER
-
批准号:6633541
-
项目类别:
-
资助金额:$41.67万
-
财政年份:2000
-
负责人:RALPH A. REISFELD
-
依托单位:
NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER
-
批准号:6514229
-
项目类别:
-
资助金额:$41.67万
-
财政年份:2000
-
负责人:RALPH A. REISFELD
-
依托单位:
NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER
-
批准号:6377619
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2000
-
负责人:RALPH A. REISFELD
-
依托单位:
NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER
-
批准号:6196918
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2000
-
负责人:RALPH A. REISFELD
-
依托单位:
IMMUNOTHERAPEUTIC MODULATION OF ANGIOGENESIS IN CANCER
-
批准号:2907651
-
项目类别:
-
资助金额:$13.36万
-
财政年份:1999
-
负责人:RALPH A. REISFELD
-
依托单位:
IMMUNOTHERAPEUTIC MODULATION OF ANGIOGENESIS IN CANCER
-
批准号:6173843
-
项目类别:
-
资助金额:$11.45万
-
财政年份:1999
-
负责人:RALPH A. REISFELD
-
依托单位:
CYTOKINE AND ANTI-RECEPTOR ANTIBODY FUSION PROTEINS
-
批准号:6102194
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1997
-
负责人:RALPH A. REISFELD
-
依托单位:
NEW TUMOR MODELS FOR THE DEVELOPMENT OF IMMUNOTHERAPY
-
批准号:3549514
-
项目类别:
-
资助金额:$28.01万
-
财政年份:1990
-
负责人:RALPH A. REISFELD
-
依托单位:
NEW TUMOR MODELS FOR THE DEVELOPMENT OF IMMUNOTHERAPY
-
批准号:3549515
-
项目类别:
-
资助金额:$26.83万
-
财政年份:1990
-
负责人:RALPH A. REISFELD
-
依托单位:
NEW TUMOR MODELS FOR THE DEVELOPMENT OF IMMUNOTHERAPY
-
批准号:3549516
-
项目类别:
-
资助金额:$29.78万
-
财政年份:1990
-
负责人:RALPH A. REISFELD
-
依托单位:
MOLECULAR PROFILE OF MELANOMA AND NEUROBLASTOMA ANTIGENS
-
批准号:2090776
-
项目类别:
-
资助金额:$77.86万
-
财政年份:1986
-
负责人:RALPH A. REISFELD
-
依托单位:
MOLECULAR PROFILE OF MELANOMA AND NEUROBLASTOMA ANTIGENS
-
批准号:2390677
-
项目类别:
-
资助金额:$89.02万
-
财政年份:1986
-
负责人:RALPH A. REISFELD
-
依托单位:
MOLECULAR PROFILE OF MELANOMA AND NEUROBLASTOMA ANTIGENS
-
批准号:3479330
-
项目类别:
-
资助金额:$76.36万
-
财政年份:1986
-
负责人:RALPH A. REISFELD
-
依托单位:
MOLECULAR PROFILE OF MELANOMA AND NEUROBLASTOMA ANTIGENS
-
批准号:3479334
-
项目类别:
-
资助金额:$68.78万
-
财政年份:1986
-
负责人:RALPH A. REISFELD
-
依托单位:
海外基金